Cite
MYC Up-regulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer
MLA
Tomonari Suetsugu, et al. “MYC Up-Regulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer.” In Vivo, vol. 35, Jan. 2021, pp. 203–13. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f4005b34d62670685ac42de65811886e&authtype=sso&custid=ns315887.
APA
Tomonari Suetsugu, Hiroyuki Tomita, Itaru Yasufuku, Ryutaro Mori, Takeharu Imai, Masahiro Fukada, Takao Takahashi, Kazuhiro Yoshida, Nobuhisa Matsuhashi, Takazumi Kato, Yoshinori Iwata, Akira Hara, Hisashi Imai, Naoki Okumura, & Yoshihiro Tanaka. (2021). MYC Up-regulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer. In Vivo, 35, 203–213.
Chicago
Tomonari Suetsugu, Hiroyuki Tomita, Itaru Yasufuku, Ryutaro Mori, Takeharu Imai, Masahiro Fukada, Takao Takahashi, et al. 2021. “MYC Up-Regulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer.” In Vivo 35 (January): 203–13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f4005b34d62670685ac42de65811886e&authtype=sso&custid=ns315887.